Tag: pharmaceutical news
Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III
Zydus Lifesciences Limited, in collaboration with the Indian Council of Medical Research (ICMR), has announced the successful completion of Phase II Proof-of-Concept trials and approval...
Johnson & Johnson Secures FDA Approval for Dual-Energy Cardiac Ablation Catheter
Johnson & Johnson has secured U.S. regulatory clearance for its newest electrophysiology device, the Dual Energy THERMOCOOL SMARTTOUCH SF Platform. The system lets doctors...
World’s First Once-Weekly Basal Insulin Now in India as Novo Nordisk Launches Awiqli®
In a major milestone for diabetes management, India has become one of the first countries globally to introduce Awiqli, the world’s first once-a-week basal insulin...
Alembic Pharmaceuticals receives final USFDA approval for Dapsone Gel, 5%for topical treatment of acne vulgaris
Alembic Pharmaceuticals Limited has secured final regulatory clearance from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for...
FDA Approves AbbVie’s SKYRIZI®️ for Pediatric Patients with Psoriatic Disease
AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for children aged six and older living with moderate-to-severe plaque...
Novartis strikes a $1.9B partnership with Antares Therapeutics to tackle “undruggable” cancer targets.
Novartis has entered into a strategic collaboration and license agreement with Antares Therapeutics to discover and develop next-generation small molecule oncology treatments. The transaction...
